Alzheon
Alzheon shies away from $81m IPO
April 30, 2018Sales and Marketing Alzheon, biotech, drugs, pharma, pharmaceutical
Alzheon, a tiny biotech based in the Boston area, had initially launched its roadshow for an IPO potentially worth up …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
